The benefits, costs and feasibility of a low incidence COVID-19 strategy.
Czypionka T, Iftekhar EN, Prainsack B, Priesemann V, Bauer S, Calero Valdez A, Cuschieri S, Glaab E, Grill E, Krutzinna J, Lionis C, Machado H, Martins C, Pavlakis GN, Perc M, Petelos E, Pickersgill M, Skupin A, Schernhammer E, Szczurek E, Tsiodras S, Willeit P, Wilmes P.
Czypionka T, et al. Among authors: wilmes p.
Lancet Reg Health Eur. 2022 Feb;13:100294. doi: 10.1016/j.lanepe.2021.100294. Epub 2022 Jan 2.
Lancet Reg Health Eur. 2022.
PMID: 35005678
Free PMC article.
Review.